Ligand · CT9
CT9 · 4-[5-(trans-4-aminocyclohexylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-7-ylamino]-N,N-dimethylbenzenesulfonamide
CT9, 4-[5-(trans-4-aminocyclohexylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-7-ylamino]-N,N-dimethylbenzenesulfonamide (C23 H33 N7 O2 S, 471.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- CT9
- Formula
- C23 H33 N7 O2 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CT9 in 2 structures; the first of them:
- 1Y91 · Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor · CT9 A401 · binds ILE10, GLY11, GLU12, GLY13, TYR15, VAL18, ALA31, VAL64 and 14 more
- 1Y91 · Crystal structure of human CDK2 complexed with a PYRAZOLO[1, 5-A]PYRIMIDINE inhibitor · CT9 A401 · binds ILE10, GLY11, GLU12, GLY13, TYR15, VAL18, ALA31, VAL64 and 14 more
Residues it binds most
ALA 2, ASP 2, GLN 2, GLU 2, GLY 2, LEU 2, LYS 2, PHE 2, VAL 2, ASN 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.